PicoQuant’s Quantum Symposium covered a wide range of photonic quantum technologies

From May 22 to 24, 2019, PicoQuant held its second international symposium on “Single Photon Based Quantum Technologies” in Berlin. The three day event brought together scientists from various areas of quantum technologies to report on and discuss the latest developments in single-photon detectors and sources, metrology and sensing, correlations and entanglement, communication and QKD, Read more about PicoQuant’s Quantum Symposium covered a wide range of photonic quantum technologies[…]

Avoid animal testing – MAT and rFC as persuasive alternatives

Already at the end of the 19th century it became known that injections can cause severe fever in patients. Substances causing this kind of reactions are called pyrogens, which have been analyzed over the following decades very intensely. A first animal (rabbit) test was developed using the fact that rabbits do also develop a fever Read more about Avoid animal testing – MAT and rFC as persuasive alternatives[…]

TissUse Launches New Product Brand HUMIMIC

TissUse, the Berlin-based pioneers in Human-on-a-Chip developments, have launched their new product brand HUMIMIC. From now on, all of the company’s products will be marketed under this common brand. As a result, TissUse GmbH’s products will have a uniform name and appearance under the HUMIMIC brand. This will make it even easier for customers to Read more about TissUse Launches New Product Brand HUMIMIC[…]

QIAGEN’s QuantiFERON®-TB Access development program gains recognition from United Nations initiative for health innovation

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that QuantiFERON®-TB Access, a new solution under development for diagnosis of latent tuberculosis (TB) infection in low-resource regions with a high disease burden of tuberculosis, will be recognized by the Joint United Nations Programme on HIV/AIDS (UNAIDS) at the organization’s Health Innovation Exchange from May Read more about QIAGEN’s QuantiFERON®-TB Access development program gains recognition from United Nations initiative for health innovation[…]

New test rig components for faster development and validation

Numerical simulations have massively accelerated product development over the past few decades. A variety of scenarios can be tested in a short time and the number of necessary prototypes has been steadily reduced. Nevertheless, physical tests are widespread and will not lose significance over the next few decades. Numerical models must be validated and approval Read more about New test rig components for faster development and validation[…]

Digitalization in the craft trades, is that possible?

Digitalization – turning data into useful information – makes energy production more effective and also leads to considerable energy savings. mycon installs the first ControlMaster system for monitoring heat exchangers on the basis of algorithms as part of the BAFA-funded "Einsparzähler (smart meters)" project. The successful cooperation between mycon and the Hamburg University of Applied Read more about Digitalization in the craft trades, is that possible?[…]

PicoQuant welcomes Scientifica to the LSM Upgrade Kit Family

PicoQuant warmly welcomes Scientifica to its family of Laser Scanning Microscope (LSM) Upgrade Kits. This new Upgrade Kit is an integrated and flexible Fluorescence Lifetime Imaging (FLIM) solution for both HyperScope and VivoScope multiphoton microscopes from Scientifica, enabling users to simultaneously acquire fluorescence intensity and lifetime images in up to two color channels. This combination of Read more about PicoQuant welcomes Scientifica to the LSM Upgrade Kit Family[…]

QIAGEN launches first FDA-approved companion diagnostic using FGFR alterations to help guide the treatment of metastatic urothelial cancer

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. launch of its novel therascreen® FGFR RGQ RT-PCR Kit (therascreen FGFR Kit) as a companion diagnostic to help guide the use of the newly approved FGFR kinase inhibitor, BALVERSA™ (erdafitinib), developed by Janssen Biotech, Inc. (Janssen). The test will aid in identifying patients Read more about QIAGEN launches first FDA-approved companion diagnostic using FGFR alterations to help guide the treatment of metastatic urothelial cancer[…]

PTT Global Chemical chooses hte for independent commercial catalyst evaluation in hydroprocessing

hte – the high throughput experimentation company has been selected by PTT Global Chemical Public Company Limited (GC), a leading Asian integrated petrochemical and refining company, to evaluate hydroprocessing commercial catalysts under commercially relevant conditions for a catalyst change-out in its refinery in Rayong, Thailand. For this catalyst benchmarking, hte has used its latest 24-fold Read more about PTT Global Chemical chooses hte for independent commercial catalyst evaluation in hydroprocessing[…]

TissUse grants first Smart Hair Transplant (SHT) License in Japan

For the first time, TissUse has granted development and distribution rights of its existing Smart Hair Transplant (SHT) technology to J. Hewitt, a Japan-based biopharmaceutical company focused on creating transformative regenerative medicine for aesthetic surgery. Under the terms of this agreement, TissUse grants J. Hewitt an exclusive license in Japan for the development of novel Read more about TissUse grants first Smart Hair Transplant (SHT) License in Japan[…]